Industry Collaboration Interpharma is a Swiss association of 24 research-based pharmaceutical companies, presenting a networked platform for partnership outreach, licensing discussions, and joint initiatives in innovation, manufacturing, and policy influence.

R&D Focus With involvement in next-generation vaccines and COVID-19 solutions, Interpharma signals ongoing interest in advanced biotechnologies and vaccine development partnerships that can be explored for co-development, funding, or supply arrangements.

Geographic Reach Headquartered in Basel with a map of member locations, there are collaboration opportunities across multiple sites in Switzerland and internationally, enabling regional supply chain coordination, clinical trial networks, and regional market access discussions.

Policy & IP Interpharma advocates for strong intellectual property protections and favorable innovation conditions, suggesting sales opportunities around technology licensing, patent-supported partnerships, and advisory services related to regulatory strategy.

Market Positioning As an umbrella body with substantial member revenues and global ties, Interpharma can be a conduit for strategic partnerships, co-marketing, and access to a broad client base seeking innovative pharmaceutical solutions, manufacturing capabilities, and digital health integrations.